Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 59 | SFEBES2018 | Next issue

Society for Endocrinology BES 2018

Glasgow, UK
19 Nov 2018 - 21 Nov 2018

Card image cap
The Society for Endocrinology BES will take place 19-21 Nov 2018 in Glasgow. Come and exchange knowledge, share experiences and strengthen collaborations across our global community of endocrinologists.

Poster Presentations

Neoplasia, cancer & late effects

Previous section
Diabetes & cardiovascular
Table of contents
Next section
Neuroendocrinology and pituitary

ea0059p111 | Neoplasia, cancer & late effects

Cholesterol metabolism and chemo-resistance in breast cancer

ea0059p112 | Neoplasia, cancer & late effects

Use of glucocorticoids following immunotherapy for cancer

ea0059p113 | Neoplasia, cancer & late effects

Very long term follow up of patients treated for childhood leukaemia – a single centre experience

ea0059p114 | Neoplasia, cancer & late effects

The analytical validation and clinical implications of introducing a chromogranin A referral service within Scotland

ea0059p115 | Neoplasia, cancer & late effects

Could this be the tip of the iceberg? Endocrine dysfunction of immune checkpoint inhibitors in Kent Regional Oncology Service

ea0059p116 | Neoplasia, cancer & late effects

TNFα regulates oestrogen uptake and metabolism in colorectal cancer

ea0059p117 | Neoplasia, cancer & late effects

Epigenetic inhibitor treatment reduces proliferation via induction of apoptosis in a human typical bronchial carcinoid cell line

ea0059p118 | Neoplasia, cancer & late effects

The expression pattern of miR-16 in plasma of breast cancer patients attending radiotherapy clinic in luth

ea0059p119 | Neoplasia, cancer & late effects

Oncogenic action of pituitary-tumor transforming gene (PBF) in head and neck cancer is associated with poorer overall survival

ea0059p120 | Neoplasia, cancer & late effects

Progestins used in menopausal hormone therapy is not a ‘one-size-fits-all’ for breast cancer risk

ea0059p121 | Neoplasia, cancer & late effects

Progestin-induced breast cancer: Identifying the role of progesterone receptor isoforms

ea0059p122 | Neoplasia, cancer & late effects

The human oestrogen receptor beta variant 5 (ERß5) can alter the oestrogen sensitivity of oestrogen receptor alpha positive endometrial cancer cells

ea0059p123 | Neoplasia, cancer & late effects

ELL2 and EAF2 co-regulation of AKT in prostate cancer cells

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more